Leukemia Stem Cells, Heterogeneity, and Metabolism

September 12th - 14th, 2019

Chaired By

 Martin Carroll, MD, University of Pennsyilvania
 Craig T. Jordan, Ph.D., University of Colorado
 Aaron Schimmer, MD, Ph.D., Princess Margaret Cancer Centre

Important Dates

 07/12/2019 - Travel Form )
 08/12/2019 - Abstracts )

Venue Information

Hilton Denver Inverness
200 Inverness Drive West
Englewood, CO 80112


Travel Agent Information

 Meeting #: Refer to your packet.
 Hours: 8:00am – 8:00 pm EST M-F
 Domestic: 669-210-8002
 International : 623-516-6140

About the Forbeck Foundation

 Forbeck Forum Information
 Travel Information
 General Program
 Frequently Asked Questions
 How to donate to this forum

Program Description

Acute myeloid leukemia (AML) is an aggressive hematologic malignancy with a generally poor outcome. Despite the ability to achieve remission with aggressive chemotherapy most patients relapse and ultimately succumb to their disease. Relapse disease is frequently due to chemoresistant leukemia stem cells (LSCs). Thus, new therapeutic approaches that are less toxic and better tolerated by older and frailer individuals are required. Moreover, new therapies that target the LSC population to induce cell death or promote their differentiation into more mature cells are required. The last few years have seen tremendous advances in our understanding of LSC biology and potential new therapies to target these cells. Therefore, we believe this is a critical time to convene a group of experts to synthesize new therapeutic directions. Thus, our proposed Forbeck conference will bring together a multi-disciplinary group of leading experts (basic scientists, translational scientists and clinical trialists) to design compelling strategies for translational/clinical studies.

Participant Information

Participant Institution
Julie Aurore Losman, MD, PhD Dana-Farber Cancer Institute
Martin Carroll, MD University of Pennsylvania
Jean Emmanuel Sarry, PhD Cancer Research Center of Toulouse - Inserm
Maria Figueroa, PhD University of Miami
Monica Guzman, PhD Cornell Medical College
Takahiro Ito, PhD University of Georgia
Craig Jordan, PhD University of Colorado
Harry Leighton Grimes, PhD Cincinnati Children's Hospital
Ross Levine, MD Memorial Sloan Kettering
Ravi Majeti, MD Stanford University
Steven Man Cheong Chan Princess Margaret Cancer Center
Emmanuelle Passegue, PhD Columbia University
Dan Pollyea, MD University of Colorado
Aaron Schimmer, MD, PhD University of Toronto
Liran Shlush
Uli Steidl, PhD Albert Einstein University
Jennifer Trowbridge Jackson Laboratories
Paresh Vyas

Scholars Attending

Scholar Institution
Shruti Bhatt, PhD Dana-Farber Cancer Institute
Danielle Shin, MD, PhD Stanford University
Zuzana Tothova, MD, PhD Dana-Farber Cancer Institute
Peter van Galen, PhD Massachusetts General Hospital

Airport Information

Denver International Airport (DEN) is the preferred airport as it is only 30 minutes from the meeting location.

  • Arrivals - Thursday at 1 PM, 3 PM and 5 PM
  • Departures - Sunday at 10 AM and 12 PM


The abstracts should be only one or two paragraphs outlining the theme of your presentation and should reflect the objective and spirit of the meeting (see above). Abstracts will be circulated about one week before the meeting. The meeting organizer will start requesting them a month before the meeting.

For more than 30 years, the Forbeck Foundation has proven to be an excellent steward of donor funds and has remained focused on executing its mission. Interested in sponsoring this Forum? Contact us today for more information!